Drug
Izokibep
Izokibep: highest development phase Phase 3, developed by Acelyrin. 5 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Acelyrin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Izokibep NCT05905783 | Phase 3 | Hidradenitis Suppurativa |
| Izokibep NCT05623345 | Phase 2/3 | Psoriatic Arthritis |
| Izokibep NCT05355805 | Phase 2 | Hidradenitis Suppurativa |
| Izokibep NCT05384249 | Phase 2 | Uveitis |
| Izokibep NCT04706741 | Phase 2 | Uveitis |
Latest
No recent events.
Follow Izokibep on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.